Peptonic Medical AB (publ) ("Peptonic" or the "Company") announces that the United States Patent and Trademark Office (“USPTO”) has granted a patent for the relief of provoked vulvodynia (previously referred to as vestibulitis). The patent is valid until April 2041. The Company's proprietary product for the relief of vulvodynia symptoms, VagiVital …
